890,499 Shares in CVS Health Corporation $CVS Bought by Danske Bank A S

Danske Bank A S acquired a new stake in CVS Health Corporation (NYSE:CVS) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 890,499 shares of the pharmacy operator’s stock, valued at approximately $92,122,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Beaird Harris Wealth Management LLC grew its position in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 195 shares during the period. J.Safra Asset Management Corp acquired a new stake in shares of CVS Health in the 2nd quarter valued at approximately $30,000. Dunhill Financial LLC bought a new position in CVS Health during the 2nd quarter worth approximately $32,000. Swiss RE Ltd. bought a new position in CVS Health during the 4th quarter worth approximately $26,000. Finally, Sankala Group LLC acquired a new position in CVS Health during the fourth quarter valued at approximately $28,000. Institutional investors own 80.66% of the company’s stock.

Insider Activity

In other news, Director Larry Robbins sold 370,462 shares of CVS Health stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director directly owned 4,824,799 shares in the company, valued at $450,877,466.55. This trade represents a 7.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.85% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CVS. Cantor Fitzgerald increased their target price on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, July 7th. Piper Sandler reissued an “overweight” rating and issued a $113.00 price target on shares of CVS Health in a report on Monday, June 1st. TD Cowen raised their price objective on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Finally, Truist Financial boosted their target price on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $106.75.

CVS Health Trading Up 0.9%

Shares of NYSE:CVS opened at $94.87 on Wednesday. The firm has a market cap of $121.33 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 0.93 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company’s fifty day simple moving average is $102.41 and its 200 day simple moving average is $88.56.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the business posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS reported strong second-quarter results, with earnings per share rising more than 40% year over year as profitability in its Health Care Benefits segment improved. The company also raised its 2026 adjusted operating income outlook, reinforcing the recovery story. CVS Q2 EPS Gains From Improved Health Care Benefits Profitability
• Positive Sentiment: CVS appointed Teresa Heitsenrether, JPMorgan’s data and analytics chief, to its board. Her technology, analytics and operating experience could support CVS’s artificial-intelligence and data initiatives, potentially improving efficiency and decision-making across its businesses. CVS adds JPMorgan data executive to board amid AI push
• Positive Sentiment: Brokerages assigned CVS an average “Moderate Buy” rating, reflecting improved earnings momentum and optimism about Aetna’s performance. CVS Health Given Average Rating of Moderate Buy

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.